Trial Profile
Prospective Double Blind Evaluation of Levetiracetam (Keppra) for the Treatment of Cervical Dystonia.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Nov 2018
Price :
$35
*
At a glance
- Drugs Levetiracetam (Primary) ; Botulinum-Toxin-A
- Indications Torticollis
- Focus Therapeutic Use
- 21 Nov 2018 Status changed to discontinued due to review data as per sponsor decision.
- 14 Oct 2008 New trial record.